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ABSTRACT
Objectives: Objectives of the study were (1) to evaluate the knowledge about pharmacovigilance and (2) to assess the attitude toward adverse drug 
reaction (ADR) reporting among undergraduate medical students.
Methods: It is a cross-sectional, questionnaire-based study conducted in the Department of Pharmacology, Malla Reddy Medical College for Women, 
Hyderabad, Telangana, among fifth term Bachelor of Medicine, Bachelor of Surgery students (136). The questionnaire consisted of 16 questions 
dealing with knowledge, awareness, attitude about pharmacovigilance and ADR reporting. Data were analyzed and presented as percentage among 
respondents.
Results: About 58.8% of students could not identify the proper definition of pharmacovigilance and 84.5% of undergraduates have not seen ADR form. 
It was agreed among 42.6% of students that ADR reporting is a professional obligation to them and 47.7% agreed that establishing ADR monitoring 
center in every hospital is compulsory.
Conclusions: Our study revealed that though the attitude toward pharmacovigilance was appreciable among the medical students; there lies an 
insufficient knowledge and awareness about pharmacovigilance. Continued medical education programs and workshops may be helpful in the future 
to increase awareness and consequently to improve the rate of spontaneous ADR reporting among these upcoming doctors.
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INTRODUCTION
The World Health Organization (WHO) has defined pharmacovigilance 
as “the science and activities relating to the detection, assessment, 
understanding and prevention of adverse effects or any other possible 
drug-related problems” [1]. Although a new drug has to undergo various 
clinical and non-clinical trials, yet the need of pharmacovigilance 
becomes mandatory as the information generated from clinical trials 
is not sufficient to evaluate the safety of drugs with regard to adverse 
drug reaction (ADR) for its being limited to few number of patients, 
and the conditions for the use of medicines differ from that in clinical 
practice and for regular use by the patients [2]. The main objective of 
pharmacovigilance is that the drug molecule which has entered the 
market is safe for the treatment of various diseases of the general 
population who suffer from different medical conditions. Satisfactory 
reporting of suspected ADRs by health-care professionals is all 
important in this issue.
WHO definition of ADR is “a response to a drug which is noxious and 
unintended and which occurs at doses normally used in man for the 
prophylaxis, diagnosis or therapy of disease or for the modification 
of physiological function” [3]. Out of the several methods of detecting 
and analyzing ADRs, spontaneous reporting of ADR has contributed 
significantly to improved levels of pharmacovigilance. It plays an 
important role in the detection of ADRs, and many drugs with potential 
serious harmful effects have been withdrawn from the market due 
to it [4]. To boost spontaneous reporting by health-care providers, 
ADRs monitoring centers are being established in India under 
Pharmacovigilance Program of India (PvPI) [5]. Still pharmacovigilance 
is in its infancy phase in India. Lack of awareness among health-care 
professionals is one of the main reasons for this. Although studies 
reporting the level of awareness and practices of pharmacovigilance 
have been done in different parts of India [6-8], very few studies 
have focused this aspect in Telangana. Further, most of the studies 
have included health-care workers, but studies on awareness among 
undergraduate students are limited [9-11].
The Medical Council of India has recommended to teach ADR monitoring 
for undergraduate students [12]; to motivate the participation of 
health-care professionals in spontaneous reporting, it is very much 
essential to design strategies that modify both intrinsic (knowledge, 
attitude, and practices) and extrinsic (relationship between health 
professionals and their patients, the health system and the regulators) 
factors [13]. As future medical practitioners, medical students need to 
be well trained on how to recognize, prevent and report ADRs. Teaching 
pharmacovigilance to medical students makes them realize that all 
drugs can cause ADRs and it motivates them to participate in PvPI [14]. 
The right time to improve their knowledge about pharmacovigilance 
is mainly during the undergraduate course. In view of this, this study 
was undertaken to assess the awareness of pharmacovigilance and 
ADR reporting among fifth term medical undergraduate students 
at a medical college in Hyderabad. This would help us in planning 
interventions among this group of upcoming doctors.
METHODS
It is a cross-sectional, questionnaire-based survey conducted in the 
Department of Pharmacology, Malla Reddy Medical College for Women 
(MRMCW), Hyderabad, Telangana, among fifth term Bachelor of 
Medicine, Bachelor of Surgery (MBBS) students (136). The study tool 
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was a questionnaire which was designed from previous studies and 
suitably modified for our present setting. This questionnaire contains a 
total of 16 questions. Among the questions, 7 are related to knowledge 
and 2 questions are related to awareness about pharmacovigilance, 
both were of multiple choice type and 6 questions was for attitude, it 
was of modified Likert’s-type scale by ticking one of the five alternatives 
(5 point scale) viz., strongly agree, agree, neither agree or disagree 
(neutral), disagree and strongly disagree. Oral consent was taken from 
the students before the study, and they were asked not to disclose their 
identity. 20 minutes was given to fill up the questionnaire. The study 
was approved by Institutional Ethics Committee, MRMCW, Hyderabad, 
Telangana. The data were collected and expressed in percentage using 
Microsoft Office Excel software.
RESULTS
The questionnaire contains a total of 16 questions. Among the 
questions, 7 are related to knowledge and 2 questions are related to 
awareness about pharmacovigilance and it was of multiple choice 
type and 6 questions was for attitude, it was of modified Likert’s-type 
scale by ticking one of the five alternatives (5 point scale) viz., strongly 
agree, agree, neither agree or disagree (neutral), disagree and strongly 
disagree.
Table 1 shows knowledge of pharmacovigilance among undergraduate 
students. 58.8% of students could not identify the proper definition 
of pharmacovigilance, but 86.7% of students could tell that Central 
Drug Standard Control Organization (CDSCO) is the regulatory body 
for drug safety issues in India. 61% of students were not able to tell 
when a serious adverse drug event in India should be reported to the 
regulatory body in India. Among the students, only 36.7% of them were 
able to tell that International Centre for Reporting ADR is Uppsala 
(Fig. 1). Only 71.3% of students had knowledge that doctors, nurses, 
and pharmacists are the health-care professional responsible for ADR 
reporting (Fig. 2). Naranjo algorithm is the used to assess causality 
assessment of suspected ADR was answered correctly by 43.3% of 
students. 80.14% of them were able to make out that Vigibase is the 
WHO online database for reporting ADRs.
Table 2 shows awareness of pharmacovigilance among medical students. 
59.55% of students could tell that a drug can be banned because of ADR. 
The students were asked to give an example for a drug banned because 
of ADR; the reply was thalidomide, phenylpropanolamine, fenfluramine, 
cisapride, phenformin, and valdecoxib. When asked whether they have 
seen ADR reporting form, 84.5% of students reported that they have 
not seen ADR reporting form.
Table 3 shows assessment of attitude by Likert’s-type scale regarding 
ADR reporting among students. It was good to see that 42.6% of 
students strongly agreed to the fact that ADR reporting is a professional 
obligation to them. When asked whether establishing ADR monitoring 
center should be made compulsory in every hospital, 47.7% of them 
strongly agreed to the fact. 46.3% of students agreed to the fact that 
it is necessary to report ADR. Pharmacovigilance should be taught in 
detail to health-care professionals is strongly agreed among 53.6% 
of students. 39.7% felt ADR reporting is essential to reduce the cost 
of medical care in India. It was strongly agreed by 46.3% of students 
that pharmacovigilance activities will help to reduce morbidity and 
mortality. 51.4% of students felt practicing pharmacovigilance will 
bring improvement in the quality of life.
DISCUSSION
ADR reporting is an integral part of pharmacovigilance and is 
important for patient care. Underreporting of ADR is a major threat to 
the success of pharmacovigilance program [15]. The ultimate aim of 
Table 1: Knowledge of pharmacovigilance
Q.No. Question Response in % (out of 136)
Correct Wrong
1. Definition of Pharmacovigilance 41.1% (56) 58.8% (80)
2. A serious adverse drug event (ADR) in India should be reported to the regulatory body within 39% (52) 61% (84)
3. Government regulatory body involved for drug safety issues in India 86.7% (118) 13.2% (18)
4. The health-care professionals responsible for reporting ADR in a hospital is/are 71.3% (97) 28.6% (39)
5. Where is the international center for monitoring ADR located? 36.7% (50) 63.2% (86)
6. How to asses causality assessment of suspected ADR? 43.3% (59) 55.8% (76)
7. Is Vigibase a WHO online database for reporting ADR? 80.14% (109) 19.85% (27)
ADR: Adverse drug reaction, WHO: World Health Organization
Fig. 1: International Center for monitoring adverse drug 
reaction - Data are represented in percentage (%)
Fig. 2: Health-care professionals responsible for reporting 
adverse drug reaction in hospital - Data are represented in 
percentage (%)
Table 2: Awareness of pharmacovigilance
Q.No. Question Response in % 
(out of 136)
Yes No
1. Can a drug be banned because 
of adverse drug reaction? If 
yes, name the drug
59.5% (81) 40.4% (55)
2. Have you seen ADR reporting 
form?
15.4% (21) 84.5% (115)
ADR: Adverse drug reaction
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pharmacovigilance is to ensure safe and rational use of medicine. The 
most important outcome of pharmacovigilance is the prevention of 
patients being affected unnecessarily by the negative consequences of 
pharmacotherapy [16].
In our study, 58.8% of students did not know WHO standard definition 
of pharmacovigilance though this topic was dealt to them briefly during 
their general pharmacology classes which are similar to studies done 
earlier [17,18]. However, the majority of students could tell CDSCO is 
the regulatory body for drug safety issues in India; the result of which 
is similar to other studies [19,20]. From our study, it was seen that a 
majority of students have not seen the ADR reporting form at all. 
Educational intervention is very much essential to these undergraduate 
students to get a good grasp of pharmacovigilance. Hence, this topic 
must be dealt separately during their theory classes and initiation must 
be made for inclusion how to fill ADR form and causality assessment 
of ADR in our practical syllabus. With regard to attitude toward ADR 
reporting, students response was satisfactory. The majority felt 
that pharmacovigilance should be taught in detail to health-care 
professionals and practicing it will bring improvement in the quality 
of life, which correlates with another study [21]. The students also felt 
that phamacovigilance will definitely help to reduce the morbidity, 
mortality and will bring improvement in the quality of life. 42.6% of 
students felt ADR reporting is a professional obligation to them which is 
similar to other studies [20]. In studies done among doctors by Thomas 
et al., Gupta and Udupa, 98%, 80.9% respectively, felt ADR reporting 
is a professional to them [22,23]. This difference in attitude between 
doctors and students might be because of increased awareness among 
doctors compared to undergraduate students.
Medical students who have real knowledge of pharmacovigilance are 
likely to provide more adequate health services in their future practice. 
So with a positive attitude toward ADR reporting, many interventions 
can be made in the students curriculum such as continued medical 
education, seminars, and workshops to strengthen the system and to 
improve the ADR reporting culture in our country so that students 
realize that all medicines can cause ADRs. The students can get an 
actual practical knowledge by visiting a pharmacovigilance center and 
by observing its functioning carefully. Even students of dental, nursing, 
pharmacy, and physiotherapy courses can be sensitized to spread the 
awareness about it. The result of this study is only a tip of iceberg 
with reference to the knowledge, awareness, and attitude of students 
toward pharmacovigilance. Many studies from different institutions 
of different geographical areas and different health-care professionals 
should be conducted in the future order to improvise the need for ADR 
reporting in India.
CONCLUSION
Our study suggested that though the attitude toward pharmacovigilance 
was appreciable among the medical students, there lies an insufficient 
knowledge and awareness about pharmacovigilance. Widening the 
teaching programs for students during their undergraduate training 
might provide a solution to strengthen ADR reporting system.
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